Project Number 5P01AG014449-20 Agency/Funding Organization NIA Funding Year 2018 View Full Project Details for Cholinergic Alterations in Mild Cognitive Impairment Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 7. Circuits and Synapses b. Selective Vulnerability Researcher and Organization Principal Investigator MUFSON, ELLIOTT JAY Principal Investigator First Name ELLIOTT Principal Investigator Last Name MUFSON Awardee Organization ST. JOSEPH'S HOSPITAL AND MEDICAL CENTER Awardee State Arizona Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-11-066: NIA PROGRAM PROJECT APPLICATIONS (P01) FY Overall Cost $576,437 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official OPANASHUK, LISA A Related Resources Repository [AlzPED] Intravenous immunoglobulin reduces tau pathology and preserves neuroplastic gene expression in the 3xTg mouse model of Alzheimer's disease
